Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02956460 · ClinicalTrials.gov registry record · NA
Performance Comparison Between Fanfilcon A and Senofilcon A Sphere Lenses
A NA study of Myopia, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 4
- Study locations
NCT02956460: Completed NA study of Myopia, sponsored by CooperVision.
NCT02956460 is a NA study of Myopia that has completed, run by CooperVision. The registered enrollment target is 64 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (76% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02956460, a NA study of Myopia, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 4
- Study locations
Study Summary
Prospective, multi-center, bilateral, double-masked, randomized, cross-over, daily wear, 1 month dispensing study (2 weeks each lens pair)
Primary Outcome
Subjective assessment for comfort is assessed. Scale 0-10, 0=painful, 10=can't feel
Conditions Studied
Interventions
- DEVICE senofilcon A
- DEVICE fanfilcon A
Study Locations (4)
California
- Eric M. White O. D., Inc - San Diego
Florida
- Golden Vision - Sarasota
Kansas
- Kannarr Eye Care - Pittsburg
Pennsylvania
- Nittany Eye Associates - State College
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2016-10-27 |
| Est. Completion | 2016-12-14 |
| Phase | NA |
What the finished NCT02956460 record still lists
NCT02956460 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which senofilcon A is the first listed.
NCT02956460 reports a single indexed study location in California, Florida, Kansas.
Frequently Asked Questions
What is clinical trial NCT02956460 about?
NCT02956460 is a clinical study titled "Performance Comparison Between Fanfilcon A and Senofilcon A Sphere Lenses". Prospective, multi-center, bilateral, double-masked, randomized, cross-over, daily wear, 1 month dispensing study (2 weeks each lens pair)
What is the current status of trial NCT02956460?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2016-10-27. Estimated completion is 2016-12-14.
What conditions does trial NCT02956460 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT02956460?
The interventions under investigation include: senofilcon A (DEVICE), fanfilcon A (DEVICE).
Who is sponsoring clinical trial NCT02956460?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02956460 being conducted?
This trial has 4 study locations across California, Florida, Kansas, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02956460's enrollment target sits among peer trials
64 57th of 90 higher than 34 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI